PYC Chart and Technical Analysis, page-155

while i appreciate your humour/candour its worth remembering that it’s the birds and in reality even the trees outside the class room window, in fact even the window, that they cant see as they lose peripheral vision early and loss of central vision is a very very late feature of this disease.

yesterdays trading suggests there is a big fish accumulating, or several. Perhaps the instos building a big stake prior to June 30 and helping their 8c investment performance along at the same time.

WE now have 4 analysts providing reports on this company with current valuations between 22c and 38c approx as the current “ value” of this stock. They all imply various discounts for uncertainties but none of them factor in the 60% or so probability that RH suggests is real given the nature of the drugs and method of administration. This could be the beginning of the rerate we are so overdue.

These reports also state that once derisked the stock will be worth well north of $1!